Update 21 September 2020: Despite claims made on social media there is still no evidence that FAI has been approved, or undergoing clinical trial, or being legally used anywhere.
: 8 June 2020. Social media posts claim that the Indonesian health authorities had agreed to conduct clinical trials on Fabunan Antiviral Injection. The claims appear only from know promoters of FAI. Despite the importance of such a move, if true, it remains unconfirmed by medical news and information outlets, the WHO database of ongoing Covid-19 measures, Indonesian media, Philippine media or any reliable source. Given the track record of misinformation by FAI promoters (Such as claims that the Philippine FDA had approved FAI), we catalogue the claim as dubious.Clinical trials must be registered, yet no such trial can be found on clinical trial databases such as centerwatch.com or clinicaltrials.gov.Update: 31 May. Malacanang corrects false information regarding FAI.
Important update: 27 May: The Fabunan Medical Clinic has closed.
Update, 24 May, 2020: The Philippine FDA has issued a cease-and-desist order, DoH is ‘working up a case’ against Dr Willie Fabunan. Here for more information.
New information is emerging on the Fabunan claims which are now being verified. Updates will be made as these are checked.
Corrections of factual errors are welcome in the comments section, which is moderated.
Right now, things are little different from the 1918 Spanish flu pandemic which killed up.to 18 million people, according to some estimates. Many of the rumoured ‘cures’ have re-emerged in the Covid-19 crisis. You’ll find some familiar claims in this recording.
The case of the Fabunan patented jollop raises a number of red-flags suggesting that a patented mixture of painkiller and a steroid for treating Covid-19, Fabunan Antiviral Injection, is, prehaps less than is claimed for it. It is not encouraging that development was led by an accupuncturist, Willie Fabunan.